TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS - Patent 1937244

(19)

(11)

EP 1 937 244 A2

(12)

(88)	Date of publication A3:
	27.12.2007

(43)	Date of publication:
	02.07.2008 Bulletin 2008/27

(21)	Application number: 06825280.8

(22)	Date of filing: 02.10.2006

(51)

International Patent Classification (IPC):

A61K 31/203^(2006.01)
A61K 31/07^(2006.01)
C07D 311/58^(2006.01)

A61K 31/137^(2006.01)
C07C 57/48^(2006.01)
C07K 14/705^(2006.01)

(86)	International application number:
	PCT/US2006/038252

(87)	International publication number:
	WO 2007/041398 (12.04.2007 Gazette 2007/15)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK RS

(30)

Priority:

30.09.2005 US 722264 P

(71)	Applicant: Vitae Pharmaceuticals, Inc.
	Fort Washington, PA 19034 (US)

(72)	Inventor:
	CHANDRARATNA, Roshantha, A. Laguna Hills, CA 92653 (US)

(74)	Representative: Bublak, Wolfgang et al
	European Patent Attorney Bardehle, Pagenberg, Dost, Altenburg, Geissler Postfach 86 06 20 81633 München 81633 München (DE)

(54)	TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS